Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

Professor Helen McShane and her team have made a discovery that could improve our chances of developing an effective vaccine against Tuberculosis. The researchers have identified new biomarkers which have shown for the first time why immunity from the BCG vaccine is so variable. The biomarkers will also provide valuable clues to assess whether potential new vaccines could be effective.